Eaton Vance Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$5.43M Buy
2022
Q2
$5.06M Buy
2022
Q1
$3.57M Buy
2021
Q4
$24K Sell
2021
Q3
$3K Buy
2021
Q2
$12K Buy